The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension

BACKGROUND: Coronavirus disease 2019 (COVID-19), caused by a novel coronavirus (designated as SARS-CoV-2) has become a pandemic worldwide. Based on the current reports, hypertension may be associated with increased risk of sever condition in hospitalized COVID-19 patients. Angiotensin-converting enz...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zheyong, Cao, Jiatian, Yao, Yumeng, Jin, Xuejuan, Luo, Zhe, Xue, Yuan, Zhu, Chouwen, Song, Yanan, Wang, Ying, Zou, Yunzeng, Qian, Juying, Yu, Kaihuan, Gong, Hui, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210199/
https://www.ncbi.nlm.nih.gov/pubmed/32395474
http://dx.doi.org/10.21037/atm.2020.03.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210199/
https://www.ncbi.nlm.nih.gov/pubmed/32395474
http://dx.doi.org/10.21037/atm.2020.03.229

Ejemplares similares